D-dimer levels before HIV seroconversion remain elevated even after viral suppression and are associated with an increased risk of non-AIDS events

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Freiberg, Matthew S ^a   Bebu, Ionut ^f   Tracy, Russell ^e   So Armah, Kaku ^h   Okulicz, Jason ^b,c   Ganesan, Anuradha ^b,d,k   Armstrong, Adam ^b,g   O'Bryan, Thomas ^b,c,k   Rimland, David ⁱ   Justice, Amy C ^j   Agan, Brian K ^b,k  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

^g Peru   (Peru)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; INTERLEUKIN 6; ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEROCONVERSION; VIRUS INHIBITION; ACQUIRED IMMUNODEFICIENCY SYNDROME; BLOOD; COMPLICATION; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; METABOLISM; PATHOGENICITY; PROSPECTIVE STUDY; VIROLOGY; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-RETROVIRAL AGENTS; BIOMARKERS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HIV; HIV INFECTIONS; HUMANS; INTERLEUKIN-6; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SEROCONVERSION; VIRAL LOAD;

EID: 84964607690     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152588     Document Type: Article

References (32)

1. Althoff KN, McGinnis KA, Wyatt CM, Freiberg MS, Gilbert C, Oursler KK, et al. Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clin Infect Dis. 2015;60(4):627-38. doi: 10.1093/cid/ciu869 PMID: 25362204; PubMed Central PMCID: PMC4318916.
2. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, et al. CD4+count-guided interruption of antiretroviral treatment. The New England journal of medicine. 2006;355(22):2283-96. Epub 2006/12/01. doi: 10.1056/NEJMoa062360 PMID: 17135583.
3. Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA internal medicine. 2013;173(8):614-22. doi: 10.1001/jamainternmed.2013.3728 PMID: 23459863.
4. Neuhaus J, Jacobs DR Jr., Baker JV, Calmy A, Duprez D, La Rosa A, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis. 2010;201(12):1788-95. Epub 2010/05/08. doi: 10.1086/652749 PMID: 20446848; PubMed Central PMCID: PMC2872049.
5. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoSMed. 2008;5(10):e203. Epub 2008/10/24. 08-PLME-RA-0628 [pii] doi: 10.1371/journal.pmed.0050203 PMID: 18942885; PubMed Central PMCID: PMC2570418.
6. Group ISS, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. The New England journal of medicine. 2015;373(9):795-807. doi: 10.1056/NEJMoa1506816 PMID: 26192873; PubMed Central PMCID: PMCPMC4569751.
7. Kuller L, Group SS, editors. Elevated Levels of Interleukin-6 and D-dimer Are Associated with an Increased Risk of Death in Patients with HIV. Conference on Retroviruses and Opportunistic Infections; 2008 February 3-6; Boston, Massachusetts.
8. Marconi VC, Grandits GA, Weintrob AC, Chun H, Landrum ML, Ganesan A, et al. Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U. S. Military HIV Natural History Study. AIDS research and therapy. 2010;7:14. doi: 10.1186/1742-6405-7-14 PMID: 20507622; PubMed Central PMCID: PMC2894737.
9. Rubertone MV, Brundage JF. The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance. American journal of public health. 2002;92(12):1900-4. Epub 2002/11/28. PMID: 12453804; PubMed Central PMCID: PMC1447349.
10. Brodine SK, Shaffer RA, Starkey MJ, Tasker SA, Gilcrest JL, Louder MK, et al. Drug resistance patterns, genetic subtypes, clinical features, and riskfactors in military personnel with HIV-1 seroconversion. Ann Intern Med. 1999;131(7):502-6. Epub 1999/10/03. PMID: 10507958.
11. Dawson DA, Pulay AJ, Grant BF. A comparison of two single-item screeners for hazardous drinking and alcohol use disorder. Alcoholism, clinical and experimental research. 2010;34(2):364-74. Epub 2009/12/03. doi: 10.1111/j.1530-0277.2009.01098.x PMID: 19951291.
12. Armah KA, McGinnis K, Baker J, Gibert C, Butt AA, Bryant KJ, et al. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis. 2012;55(1):126-36. doi: 10.1093/cid/cis406 PMID: 22534147; PubMed Central PMCID: PMC3493182.
13. Betene ADC, De Wit S, Neuhaus J, Palfreeman A, Pepe R, Pankow JS, et al. Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy. J Acquir Immune DeficSyndr. 2014;67(5):538-46. doi: 10.1097/QAI. 0000000000000354 PMID: 25393940; PubMed Central PMCID: PMCPMC4231540.
14. Rincon M, Irvin CG. Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci. 2012;8(9):1281-90. doi: 10.7150/ijbs.4874 PMID: 23136556; PubMed Central PMCID: PMCPMC3491451.
15. Peters L, Neuhaus J, Duprez D, Neaton JD, Tracy R, Klein MB, et al. Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study. J Clin Virol. 2014;60(3):295-300. doi: 10.1016/j.jcv. 2014.03.017 PMID: 24793968.
16. Armah KA, Quinn EK, Cheng DM, Tracy RP, Baker JV, Samet JH, et al. Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study. BMC infectious diseases. 2013;13:399. doi: 10.1186/1471-2334-13-399 PMID: 23987993; PubMed Central PMCID: PMCPMC3848623.
17. Efron B, Tibshirani RJ. An Introduction to the Bootstrap (Chapman & Hall/CRC Monographs on Statistics & Applied Probability). 1994.
18. Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately? Blood. 2009;114(12):2367-74. doi: 10.1182/blood-2009-05-199208 PMID: 19584396.
19. Palella FJ Jr., Gange SJ, Benning L, Jacobson L, Kaplan RC, Landay AL, et al. Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study. AIDS. 2010;24(11):1657-65. Epub 2010/07/01. doi: 10.1097/QAD.0b013e3283389dfa 00002030-201007170-00006 [pii]. PMID: 20588104.
20. Wada NI, Jacobson LP, Margolick JB, Breen EC, Macatangay B, Penugonda S, et al. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation. AIDS. 2015;29(4):463-71. doi: 10.1097/QAD.0000000000000545 PMID: 25630041; PubMed Central PMCID: PMCPMC4311407.
21. Baker JV, Brummel-Ziedins K, Neuhaus J, Duprez D, Cummins N, Dalmau D, et al. HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation. Journal of the American Heart Association. 2013;2(4):e000264. doi: 10.1161/JAHA.113.000264 PMID: 23896681; PubMed Central PMCID: PMC3828789.
22. Borges AH, O'Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, et al. Factors associated with D-dimer levels in HIV-infected individuals. PLoSOne. 2014;9(3):e90978. doi: 10.1371/journal.pone. 0090978 PMID: 24626096; PubMed Central PMCID: PMC3953205.
23. Nordell AD, McKenna M, Borges AH, Duprez D, Neuhaus J, Neaton JD, et al. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. Journal of the American Heart Association. 2014;3(3):e000844. doi: 10.1161/JAHA.114.000844 PMID: 24870935; PubMed Central PMCID: PMC4309077.
24. Koethe JR, Dee K, Bian A, Shintani A, Turner M, Bebawy S, et al. Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy. AIDS Res Hum Retroviruses. 2013;29(7):1019-25. doi: 10.1089/AID. 2013.0016 PMID: 23469772; PubMed Central PMCID: PMC3685684.
25. Fuster D, Tsui JI, Cheng DM, Quinn EK, Armah KA, Nunes D, et al. Interleukin-6 Is Associated with Noninvasive Markers of Liver Fibrosis in HIV-Infected Patients with Alcohol Problems. AIDS Res Hum Retroviruses. 2013. Epub 2013/04/23. doi: 10.1089/AID.2012.0348 PMID: 23601055.
26. Palella FJ Jr., Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. The New England journal of medicine. 1998;338(13):853-60. Epub 1998/03/27. doi: 10.1056/NEJM199803263381301 PMID: 9516219.
27. Justice AC, Lasky E, McGinnis KA, Skanderson M, Conigliaro J, Fultz SL, et al. Medical disease and alcohol use among veterans with human immunodeficiency infection: A comparison of disease measurement strategies. Med Care. 2006;44(8 Suppl 2):S52-60. doi: 10.1097/01.mlr.0000228003.08925. 8c PMID: 16849969.
28. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382(9903):1525-33. doi: 10.1016/S0140-6736 (13) 61809-7 PMID: 24152939; PubMed Central PMCID: PMC4058441.
29. Duprez DA, Neuhaus J, Kuller LH, Tracy R, Belloso W, De Wit S, et al. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One. 2012;7(9):e44454. doi: 10.1371/journal. pone.0044454 PMID: 22970224; PubMed Central PMCID: PMC3438173.
30. Wannamethee SG, Whincup PH, Shaper AG, Rumley A, Lennon L, Lowe GD. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. Journal of thrombosis and haemostasis: JTH. 2009;7(10):1605-11. Epub 2009/08/18. doi: 10.1111/j.1538-7836.2009.03574.x PMID: 19682232; PubMed Central PMCID: PMC2810437.
31. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101(15):1767-72. Epub 2000/04/19. PMID: 10769275.
32. Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity. 2013;39(4):633-45. doi: 10.1016/j.immuni.2013.10.001 PMID: 24138880; PubMed Central PMCID: PMC4012895.